# Molecular Early Sepsis Identification Study

> **NCT05833412** · — · UNKNOWN · sponsor: **Alejandro Rodriguez Oviedo , MD** · enrollment: 120 (estimated)

## Conditions studied

- Sepsis
- Molecular Diagnosis

## Interventions

- **DIAGNOSTIC_TEST:** Septicyte Rapid ®
- **DIAGNOSTIC_TEST:** FilmArray® blood culture identification (BCID2®)

## Key facts

- **NCT ID:** NCT05833412
- **Lead sponsor:** Alejandro Rodriguez Oviedo , MD
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-04-12
- **Primary completion:** 2023-04-17
- **Final completion:** 2024-04-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2023-05-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05833412

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05833412, "Molecular Early Sepsis Identification Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05833412. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*